retatrutide fda status Approval Status: July 2026 Update FDA Warns Companies Over Compounded

This hormone helps control blood glucose levels, insulin production, and feelings of fullness

Private treatment is available for eligible patients following a clinical assessment

Your provider may order tests if your history or intake raises a concern (thyroid issues, high blood sugar, liver history)

Catherine Schaefer, physician assistant with Shed It

Semaglutide primarily targets GLP-1, while Tirzepatide combines GLP-1 and GIP activity

At the same time, the availability of Medicares lower negotiated price for certain GLP-1 products under the Medicare Drug Price Negotiation Program (semaglutide beginning in 2027 and dulaglutide beginning in 2028) could mitigate the increase in Medicare spending that could come about from ongoing and expanded use of these medications